McGlone Suttner Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.16M Buy
14,891
+1,298
+10% +$179K 0.25% 46
2026
Q2
$1.75M Buy
13,593
+310
+2% +$36.3K 0.2% 56
2026
Q1
$1.6M Buy
13,283
+416
+3% +$48K 0.21% 51
2025
Q4
$1.35M Sell
12,867
-1,672
-12% -$157K 0.18% 59
2025
Q3
$1.22M Buy
14,539
+344
+2% +$28.3K 0.17% 59
2025
Q2
$1.12M Sell
14,195
-868
-6% -$69K 0.17% 64
2025
Q1
$1.35M Buy
15,063
+4,110
+38% +$384K 0.22% 49
2024
Q4
$1.09M Sell
10,953
-2,675
-20% -$276K 0.18% 59
2024
Q3
$1.55M Buy
13,628
+2,587
+23% +$307K 0.32% 37
2024
Q2
$1.2M Sell
11,041
-1,849
-14% -$238K 0.25% 47
2024
Q1
$1.7M Buy
12,890
+1,849
+17% +$228K 0.32% 36
2023
Q4
$1.2M Buy
11,041
+273
+3% +$28.3K 0.24% 47
2023
Q3
$1.11M Sell
10,768
-3,012
-22% -$325K 0.26% 46
2023
Q2
$1.59M Buy
13,780
+287
+2% +$32.6K 0.36% 29
2023
Q1
$1.43M Buy
13,493
+932
+7% +$101K 0.37% 31
2022
Q4
$1.39M Buy
+12,561
New +$1.28M 0.44% 32

Other funds holding MRK

McGlone Suttner Wealth Management's MRK Position: Q3 2026 in Review

McGlone Suttner Wealth Management increased its Merck (MRK) stake by 9.5% in Q3 2026, buying an estimated $179K and bringing the position to 14,891 shares worth $2.16M. The position accounts for 0.25% of the portfolio, ranked #46.

McGlone Suttner Wealth Management first reported a position in MRK in Q4 2022 and has held it in 16 quarters since. 3,979 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • McGlone Suttner Wealth Management held 14,891 shares of Merck worth $2.16M as of Q3 2026.
  • McGlone Suttner Wealth Management bought 1,298 Merck shares in Q3 2026, an estimated $179K.
  • Merck made up 0.25% of McGlone Suttner Wealth Management's portfolio in Q3 2026, its #46 holding.
  • McGlone Suttner Wealth Management first reported a position in Merck in Q4 2022 and has held it in 16 quarters since.
  • 3,979 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on McGlone Suttner Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.